PPARGC1A and neoplasm: Taken together, we propose that tumor-released circulating activin A remotely suppresses the expression of PGC1α in muscle endothelium and results in endothelial dysfunction by increasing EC death, vascular leakiness and EndMT, thereby causing cachexic muscles (Fig. 8m).